schliessen

Filtern

 

Bibliotheken

Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects

Aim: To compare the safety, immunogenicity and long-term effect of a purified vero cell cultured rabies vaccine in post-exposure subjects following 2 intramuscular regimens, Zagreb or Essen regimen. Methods: Serum samples were collected before vaccination and on days 7, 14, 42, 180 and 365...

Journal Title: Human Vaccines & Immunotherapeutics 03 June 2017, Vol.13(6), pp.1338-1345
Main Author: Shi, Nianmin
Other Authors: Zhang, Yibin , Zheng, Huizhen , Zhu, Zhenggang , Wang, Dingming , Li, Sihai , Li, Yuhua , Yang, Liqing , Zhang, Junnan , Bai, Yunhua , Lu, Qiang , Zhang, Zheng , Luo, Fengji , Yu, Chun , Li, Li
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 2164-5515 ; E-ISSN: 2164-554X ; DOI: 10.1080/21645515.2017.1279770
Link: http://www.tandfonline.com/doi/abs/10.1080/21645515.2017.1279770
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: informaworld_s10_1080_21645515_2017_1279770
title: Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects
format: Article
creator:
  • Shi, Nianmin
  • Zhang, Yibin
  • Zheng, Huizhen
  • Zhu, Zhenggang
  • Wang, Dingming
  • Li, Sihai
  • Li, Yuhua
  • Yang, Liqing
  • Zhang, Junnan
  • Bai, Yunhua
  • Lu, Qiang
  • Zhang, Zheng
  • Luo, Fengji
  • Yu, Chun
  • Li, Li
subjects:
  • Post-Exposure
  • Protective Effect
  • Rabies Vaccine
  • Safety
  • Immunogenicity
  • Biology
ispartof: Human Vaccines & Immunotherapeutics, 03 June 2017, Vol.13(6), pp.1338-1345
description: Aim: To compare the safety, immunogenicity and long-term effect of a purified vero cell cultured rabies vaccine in post-exposure subjects following 2 intramuscular regimens, Zagreb or Essen regimen. Methods: Serum samples were collected before vaccination and on days 7, 14, 42, 180 and 365...
language: eng
source:
identifier: ISSN: 2164-5515 ; E-ISSN: 2164-554X ; DOI: 10.1080/21645515.2017.1279770
fulltext: fulltext
issn:
  • 2164-5515
  • 21645515
  • 2164-554X
  • 2164554X
url: Link


@attributes
ID733749123
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid10_1080_21645515_2017_1279770
sourceidinformaworld_s
recordidTN_informaworld_s10_1080_21645515_2017_1279770
sourcesystemPC
dbid
030N
1AAJNR
2AALUX
3ABUPF
4ACENM
5ADCVX
6ADFCX
7AIJEM
8AIRBT
9ARJSQ
10BABNJ
11BLEHA
12CCCUG
13TFL
14TFW
15TTHFI
16UEQFS
17UHWXJ
pqid1861859508
display
typearticle
titleImmunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects
creatorShi, Nianmin ; Zhang, Yibin ; Zheng, Huizhen ; Zhu, Zhenggang ; Wang, Dingming ; Li, Sihai ; Li, Yuhua ; Yang, Liqing ; Zhang, Junnan ; Bai, Yunhua ; Lu, Qiang ; Zhang, Zheng ; Luo, Fengji ; Yu, Chun ; Li, Li
ispartofHuman Vaccines & Immunotherapeutics, 03 June 2017, Vol.13(6), pp.1338-1345
identifier
subjectPost-Exposure ; Protective Effect ; Rabies Vaccine ; Safety ; Immunogenicity ; Biology
descriptionAim: To compare the safety, immunogenicity and long-term effect of a purified vero cell cultured rabies vaccine in post-exposure subjects following 2 intramuscular regimens, Zagreb or Essen regimen. Methods: Serum samples were collected before vaccination and on days 7, 14, 42, 180 and 365...
languageeng
source
version4
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://www.tandfonline.com/doi/abs/10.1080/21645515.2017.1279770$$EView_record_in_Taylor_&_Francis_(Access_to_full_text_may_be_restricted)
linktorsrc$$Uhttp://www.tandfonline.com/doi/abs/10.1080/21645515.2017.1279770$$EView_record_in_Taylor_&_Francis
search
creatorcontrib
0Shi, Nianmin
1Zhang, Yibin
2Zheng, Huizhen
3Zhu, Zhenggang
4Wang, Dingming
5Li, Sihai
6Li, Yuhua
7Yang, Liqing
8Zhang, Junnan
9Bai, Yunhua
10Lu, Qiang
11Zhang, Zheng
12Luo, Fengji
13Yu, Chun
14Li, Li
titleImmunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects
description

Aim: To compare the safety, immunogenicity and long-term effect of a purified vero cell cultured rabies vaccine in post-exposure subjects following 2 intramuscular regimens, Zagreb or Essen regimen. Methods: Serum samples were collected before vaccination and on days 7, 14, 42, 180 and 365...

subject
0Post-Exposure
1Protective Effect
2Rabies Vaccine
3Safety
4Immunogenicity
5Biology
general
0English
1Taylor & Francis
210.1080/21645515.2017.1279770
3Taylor & Francis Medical Library
4Taylor & Francis Online - Journals
5Taylor & Francis (Taylor & Francis Group)
sourceidinformaworld_s
recordidinformaworld_s10_1080_21645515_2017_1279770
issn
02164-5515
121645515
22164-554X
32164554X
rsrctypearticle
creationdate2017
addtitleHuman Vaccines & Immunotherapeutics
searchscope
0informaworld_full
1informaworld3
2informaworld2
scope
0informaworld_full
1informaworld3
2informaworld2
lsr44$$EView_record_in_Taylor_&_Francis_(Access_to_full_text_may_be_restricted)
lsr45$$EView_record_in_Taylor_&_Francis
tmp01
0Taylor & Francis Medical Library
1Taylor & Francis (Taylor & Francis Group)
tmp02
030N
1AAJNR
2AALUX
3ABUPF
4ACENM
5ADCVX
6ADFCX
7AIJEM
8AIRBT
9ARJSQ
10BABNJ
11BLEHA
12CCCUG
13TFL
14TFW
15TTHFI
16UEQFS
17UHWXJ
startdate20170603
enddate20170603
lsr40Human Vaccines & Immunotherapeutics, 03 June 2017, Vol.13 (6), pp.1338-1345
doi10.1080/21645515.2017.1279770
citationpf 1338 pt 1345 vol 13 issue 6
lsr30VSR-Enriched:[pqid]
sort
titleImmunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects
authorShi, Nianmin ; Zhang, Yibin ; Zheng, Huizhen ; Zhu, Zhenggang ; Wang, Dingming ; Li, Sihai ; Li, Yuhua ; Yang, Liqing ; Zhang, Junnan ; Bai, Yunhua ; Lu, Qiang ; Zhang, Zheng ; Luo, Fengji ; Yu, Chun ; Li, Li
creationdate20170603
lso0120170603
facets
frbrgroupid8222347677783722075
frbrtype5
newrecords20180206
languageeng
topic
0Post-Exposure
1Protective Effect
2Rabies Vaccine
3Safety
4Immunogenicity
5Biology
collection
0Taylor & Francis Medical Library
1Taylor & Francis Online - Journals
prefilterarticles
rsrctypearticles
creatorcontrib
0Shi, Nianmin
1Zhang, Yibin
2Zheng, Huizhen
3Zhu, Zhenggang
4Wang, Dingming
5Li, Sihai
6Li, Yuhua
7Yang, Liqing
8Zhang, Junnan
9Bai, Yunhua
10Lu, Qiang
11Zhang, Zheng
12Luo, Fengji
13Yu, Chun
14Li, Li
jtitleHuman Vaccines & Immunotherapeutics
creationdate2017
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Shi
1Zhang
2Zheng
3Zhu
4Wang
5Li
6Yang
7Bai
8Lu
9Luo
10Yu
aufirst
0Nianmin
1Yibin
2Huizhen
3Zhenggang
4Dingming
5Sihai
6Yuhua
7Liqing
8Junnan
9Yunhua
10Qiang
11Zheng
12Fengji
13Chun
14Li
auinitN
auinit1N
au
0Shi, Nianmin
1Zhang, Yibin
2Zheng, Huizhen
3Zhu, Zhenggang
4Wang, Dingming
5Li, Sihai
6Li, Yuhua
7Yang, Liqing
8Zhang, Junnan
9Bai, Yunhua
10Lu, Qiang
11Zhang, Zheng
12Luo, Fengji
13Yu, Chun
14Li, Li
atitleImmunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects
jtitleHuman Vaccines & Immunotherapeutics
risdate20170603
volume13
issue6
spage1338
epage1345
pages1338-1345
issn2164-5515
eissn2164-554X
formatjournal
genrearticle
ristypeJOUR
abstract

Aim: To compare the safety, immunogenicity and long-term effect of a purified vero cell cultured rabies vaccine in post-exposure subjects following 2 intramuscular regimens, Zagreb or Essen regimen. Methods: Serum samples were collected before vaccination and on days 7, 14, 42, 180 and 365...

pubTaylor & Francis
doi10.1080/21645515.2017.1279770
urlhttp://www.tandfonline.com/doi/abs/10.1080/21645515.2017.1279770
lad01Human Vaccines & Immunotherapeutics
date2017-06-03